people with the e4 allele appear to have defects in both cholesterol transport and glucose metabolism, to a degree not seen in those with e2 or e3. Even though the higher risk APOE e4 protein differs from the harmless e3 one by just one amino acid, it appears to be less efficient at moving cholesterol into and especially out of the brain.
